Literature DB >> 4887514

Salmonella abony-Salmonella typhimurium recombinant nonvirulent for the mouse.

V Krishnapillai, K Karthigasu.   

Abstract

A previous genetic investigation involving a mouse-nonvirulent Salmonella abony donor (high frequency of recombination) and a virulent S. typhimurium recipient indicated that two unlinked "low-virulence" loci determined nonvirulence. A nonvirulent recombinant was analyzed to determine the basis for its nonvirulence. The recombinant was smooth (like the parental strains) and prototrophic. The doubling time in mouse serum of the recombinant and the S. abony parent (both streptomycin-resistant) was longer than that of the wild-type streptomycin-sensitive ancestor of the S. typhimurium recipient. The virulent recipient also grew poorly in serum. However, the nonvirulence of the recombinant was probably not due to its inheritance of the streptomycin-resistance allele from the donor, because other recombinants were streptomycin-resistant but still virulent. Unlike the nonvirulent S. abony (but like the S. typhimurium), the recombinant was insusceptible to rapid intravenous clearance in normal mice. It therefore appears that neither of the "low-virulence" loci determine diminished virulence by enhancing phagocytosis. Clearance of the recombinant was enhanced by opsonization with immune serum. Counts of viable bacteria in the blood, liver, and spleen of normal mice after intravenous challenge showed that the recombinant, like the S. abony donor, failed to proliferate in the tissues, whereas the virulent S. typhimurium did so markedly. It is concluded that the nonproliferation of the recombinant was determined by one or both of the "low-virulence" loci from the nonvirulent S. abony donor.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4887514      PMCID: PMC249853          DOI: 10.1128/jb.97.3.1343-1351.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  15 in total

1.  CORRELATION BETWEEN VIRULENCE AND PHAGOCYTOSIS OF GENETIC RECOMBINANT BETWEEN ESCHERICHIA COLI AND SALMONELLA TYPHIMURIUM.

Authors:  G BIOZZI; L LEMINOR; C STIFFEL; D MOUTON; F DAOULAS
Journal:  Nature       Date:  1964-05-23       Impact factor: 49.962

2.  PARTIAL PURIFICATION OF THE "PROTECTIVE" ANTIGEN OF SALMONELLA TYPHIMURIUM AND ITS DISTRIBUTION AMONGST VARIOUS STRAINS OF BACTERIA.

Authors:  C R JENKIN; D ROWLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1965-02

3.  HFR males in Salmonella abony.

Authors:  P H MAKELA
Journal:  Genetics       Date:  1963-03       Impact factor: 4.562

4.  The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system.

Authors:  C R JENKIN; D ROWLEY
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

5.  The kinetics of blood clearance o isotopically labelled Salmonella entertidis by the reticulo-endothelial system in mice.

Authors:  G BIOZZI; J G HOWARD; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Immunology       Date:  1960-01       Impact factor: 7.397

6.  The behaviour of a mutant strain of Salmonella typhimurium in experimental mouse typhoid.

Authors:  D HOBSON
Journal:  J Hyg (Lond)       Date:  1957-09

7.  Genetics and cultural properties of mutants of Salmonella typhimurium lacking glucosyl or galactosyl lipopolysaccharide transferases.

Authors:  R G Wilkinson; B A Stocker
Journal:  Nature       Date:  1968-03-09       Impact factor: 49.962

Review 8.  Revised linkage map of Salmonella typhimurium.

Authors:  K E Sanderson
Journal:  Bacteriol Rev       Date:  1967-12

9.  ALTERATIONS IN THE MOUSE VIRULENCE OF SALMONELLA TYPHIMURIUM BY GENETIC RECOMBINATION.

Authors:  V KRISHNAPILLAI; L S BARON
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

10.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

View more
  11 in total

1.  Virulence of R-Factor-Bearing Salmonella typhimurium.

Authors:  E H Thiele
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

2.  Sensitization of complement-resistant smooth gram-negative bacterial strains.

Authors:  B L Reynolds; H Pruul
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

Review 3.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

4.  Interaction of complement and polymyxin with gram-negative bacteria.

Authors:  H Pruul; B L Reynolds
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

Review 5.  Enterobacterial common antigen.

Authors:  P H Mäkelä; H Mayer
Journal:  Bacteriol Rev       Date:  1976-09

6.  Uridinediphosphogalactose-4-epimerase deficiency in Salmonella typhimurium and its correction by plasmoid-borne galactose genes of Escherichia coli K-12: effects on mouse virulence, phagocytosis, and serum sensitivity.

Authors:  V Krishnapillai
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

7.  Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis.

Authors:  M V Valtonen; M Plosila; V V Valtonen; P H Mäkelä
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

8.  Effect of enterobacterial common antigen on mouse virulence of Salmonella typhimurium.

Authors:  M V Valtonen; U M Larinkari; M Plosila; V V Valtonen; P H Mäkelä
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Role of phagocytosis in mouse virulence of Salmonella typhimurium recombinants with O antigen 6,7 or 4,12.

Authors:  M V Valtonen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.

Authors:  H J Jörbeck; S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.